Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"

A Trial of Hydroxyurea in Spinal Muscular Atrophy

NCT00485511 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)

NCT04944940 ·Status: RECRUITING

Phase II Study of Leuprolide and Testosterone for Men With Kennedy's Disease or Other Motor Neuron Disease

NCT00004771 ·Status: COMPLETED ·Phase: PHASE2

Characterization of the Clinical-epidemiological Profile of Patients With SMA5q Types II and III: Observational Study

NCT04404764 ·Status: COMPLETED

Clinical Assessment of Spinal Muscular Atrophy Type II and III (SMA Europe)

NCT01611610 ·Status: COMPLETED ·Phase: NA

Development of a Multidisciplinary Network for Clinical and Laboratory Research for SMA

NCT05866939 ·Status: UNKNOWN

Ultrasound-assisted or Landmark-based Intrathecal Administration of Nusinersen in Adult Patients With Spinal Muscular Atrophy (The EchoSpin Study)

NCT05644899 ·Status: COMPLETED

Newborn Screening for Spinal Muscular Atrophy

NCT02123186 ·Status: COMPLETED

Characterization of New Phenotypes of Patients With Spinal Muscular Atrophy Treated With SMN Restoring Therapy

NCT06321965 ·Status: RECRUITING ·Phase: NA

Study of Hepatic Function in Patients With Spinal and Bulbar Muscular Atrophy

NCT02124057 ·Status: COMPLETED

Clinical Trial of Ultra-high Dose Methylcobalamin for ALS

NCT03548311 ·Status: COMPLETED ·Phase: PHASE3

Metabolomics of Children With SMA

NCT04587492 ·Status: COMPLETED

A Study of CK-2127107 in Patients With Spinal Muscular Atrophy

NCT02644668 ·Status: COMPLETED ·Phase: PHASE2

European Registry of Patients With Infantile-onset Spinal Muscular Atrophy

NCT03339830 ·Status: COMPLETED

Clinical Trial to Evaluate the Safety and Efficacy of EXG001-307 in Patients With Spinal Muscular Atrophy Type I

NCT06576388 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Home Monitoring of Adult Patients With SMA: a Pilot Multicenter Validation Study

NCT05839145 ·Status: NOT_YET_RECRUITING ·Phase: NA

Long Term Trajectories of SMA Patients Receiving or Not Disease-modifying Treatments

NCT05768048 ·Status: RECRUITING

Personalized Medicine for SMA: a Translational Project

NCT05779956 ·Status: UNKNOWN

A Study to Learn About the Effect of Nusinersen (BIIB058) Given as Injections to Children With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec (RESPOND)

NCT04488133 ·Status: COMPLETED ·Phase: PHASE4

A Study to Learn About the Long-Term Safety of Higher Doses of Nusinersen (BIIB058) Given as Injections to Participants With Spinal Muscular Atrophy (SMA) Who Took Part in an Earlier Nusinersen Trial (ONWARD)

NCT04729907 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

MAP THE SMA: a Machine-learning Based Algorithm to Predict THErapeutic Response in Spinal Muscular Atrophy

NCT05769465 ·Status: RECRUITING

Evaluation of the Reproducibility of a Fatigability Test Fitted to Patients With Spinal Muscular Atrophy

NCT06562283 ·Status: RECRUITING ·Phase: NA

Assessing the Fertility Status of Men With Spinal Muscular Atrophy (SMA)

NCT06194539 ·Status: RECRUITING

A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy

NCT02193074 ·Status: TERMINATED ·Phase: PHASE3

Natural History of Types 2 and 3 SMA in Taiwan

NCT03300869 ·Status: UNKNOWN